These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
437 related items for PubMed ID: 21771007
1. Dental sinus tracts mimicking scrofuloderma: cutaneous presentation of underlying bisphosphonate-related osteonecrosis of the jaw. Kang HS, Lee JW, Kim JS. Clin Exp Dermatol; 2011 Aug; 36(6):624-7. PubMed ID: 21771007 [Abstract] [Full Text] [Related]
2. Bisphosphonate-related osteonecrosis of the jaw presenting as a cutaneous dental sinus tract: a case report and review of the literature. Truong SV, Chang LC, Berger TG. J Am Acad Dermatol; 2010 Apr; 62(4):672-6. PubMed ID: 20153079 [Abstract] [Full Text] [Related]
3. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538 [Abstract] [Full Text] [Related]
4. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. Kunchur R, Need A, Hughes T, Goss A. J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200 [Abstract] [Full Text] [Related]
5. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. Mavrokokki T, Cheng A, Stein B, Goss A. J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586 [Abstract] [Full Text] [Related]
15. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. Khan AA, Sándor GK, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Dempster DW, Glorieux FH, Neville AJ, Talwar RM, Clokie CM, Al Mardini M, Paul T, Khosla S, Josse RG, Sutherland S, Lam DK, Carmichael RP, Blanas N, Kendler D, Petak S, St-Marie LG, Brown J, Evans AW, Rios L, Compston JE, Canadian Association of Oral and Maxillofacial Surgeons. J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958 [Abstract] [Full Text] [Related]
16. Complication related to bisphosphonate therapy: osteonecrosis of the jaw. Lee J. J Infus Nurs; 2009 Jul; 32(6):330-5. PubMed ID: 19918142 [Abstract] [Full Text] [Related]
17. [Diphosphonate therapy and osteonecrosis of the jaw]. Løkken P, Skoglund LA, Skjelbred P. Tidsskr Nor Laegeforen; 2007 Aug 09; 127(15):1945-7. PubMed ID: 17700737 [No Abstract] [Full Text] [Related]
18. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series. Landesberg R, Wilson T, Grbic JT. Dent Today; 2006 Aug 09; 25(8):52, 54-7. PubMed ID: 16925161 [Abstract] [Full Text] [Related]
19. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. Marx RE, Sawatari Y, Fortin M, Broumand V. J Oral Maxillofac Surg; 2005 Nov 09; 63(11):1567-75. PubMed ID: 16243172 [Abstract] [Full Text] [Related]
20. Bisphosphonate-related osteonecrosis of the jaw. Feller L, Wood NH, Khammissa RA, Chikte UM, Bouckaert M, Lemmer J. SADJ; 2011 Feb 09; 66(1):30-2. PubMed ID: 21510174 [Abstract] [Full Text] [Related] Page: [Next] [New Search]